Molecular Bioelectrostatics & Drug Delivery Laboratory
Located at Northeastern University’s Interdisciplinary Science and Engineering Complex (ISEC), the Bajpayee Lab works at the intersection of biomaterials design, nanomedicine and translational research. We utilize the body’s internal electric fields to design electrically charged biomaterials using proteins, peptides and cellular materials like exosomes, for targeting difficult to reach tissues for applications in drug delivery and diagnostic imaging.
Negatively charged tissues such as cartilage, meniscus, intervertebral disc, eye, and mucosal membrane, that also tend to be dense and avascular, are ubiquitous in the human body but remain outstanding challenges for targeted drug delivery. Their degeneration is associated with several common diseases that remain untreatable due to a lack of delivery systems that can enable drugs to penetrate the negatively charged matrix and reach their cellular targets. The high negative fixed charge density, however, can be converted from being a challenge to an opportunity by engineering therapeutics at the molecular level to add optimally positively charged domains such that electrostatic interactions can enhance their transport, uptake and retention rather than hindering them. Our lab engineers targeted bioelectrical therapeutics for treatment of diseases affecting such intrinsically charged tissues. We strive to combine basic science with translational research to develop biomedical technologies for unmet clinical needs.
Follow us on Twitter @bajpayeelab | @AmbikaBajpayee

We are supported by

Our Lab News
Prof. Bajpayee was honored at Northeastern 15th Academic Honors Convocation
Prof. Bajpayee's PECASE award was celebrated at Wednesday's event (4/16) along with several other students and faculty achievers across 13 global campuses of Northeastern University. Congrats! You can read the news [HERE]!
Recap from 2025 SFB Annual Meeting!
It was a great opportunity for us to present our works on this year Society for Biomaterials (SFB) annual meeting in Chicago. Andrew Selvadoss presented a poster on cartilage-targeting hybdrid exosomes for OA treatment on Friday (4/11) and Bill Hakim presented a talk...
Our work on cartilage-targeting cationic exosomes was featured in Osteoarthritis and Cartilage Editorial!
Our recently published paper, which was spearheaded by Dr. Tanvi Pathrikar, was highlighted by Dr. Chris Evans on the latest Osteoarthritis and Cartilage (OAC) editorial. In this work, we introduced cationic exosome as a promising non-viral carrier for OA therapeutic...